Aim: To determine the place of new drugs with activity against multidrug resistant strains of microorganisms in the treatment of complicated intraabdominal infections.
Material And Methods: The incidence and distribution of pathogens isolated from intra-abdominal specimens in patients with intra-abdominal infections are analyzed.
Results: The current situation on the growth of resistant strains among pathogens causing intra-abdominal infections is rewied.